ORGANOGENESIS HOLDINGS INC. Increase (Decrease) in Other Operating Liabilities
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Increase (Decrease) in Other Operating Liabilities of $590.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was $297.00K.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was $293.00K.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was -$1.31M.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was $1.43M, a 5407.69% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in other operating liabilities for fiscal 2025 was $158.00K.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in other operating liabilities for fiscal 2024 was -$1.06M, a 1267.03% decline from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in other operating liabilities for fiscal 2023 was $91.00K, a 26.39% increase from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in other operating liabilities for fiscal 2022 was $72.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $297.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $590.00K 10-Q · filed 2026-08-06 | -$718.00K derived: sum of 3 quarters · filed 2026-08-06 | $714.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $293.00K 10-Q · filed 2026-05-07 | -$1.01M derived: sum of 2 quarters · filed 2026-05-07 | $417.00K derived: sum of 3 quarters · filed 2026-05-07 | ||
| 2025-12-31 | -$1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $124.00K derived: sum of 2 quarters · filed 2026-02-26 | $158.00K 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.47M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $34.00K 10-Q · filed 2026-08-06 | ||||
| 2024-12-31 | -$1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.12M derived: sum of 2 quarters · filed 2026-02-26 | -$1.09M derived: sum of 3 quarters · filed 2026-02-26 | -$1.06M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $52.00K derived: sum of 2 quarters · filed 2025-11-06 | $80.00K 10-Q · filed 2025-11-06 | $103.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $54.00K 10-Q · filed 2025-08-07 | $77.00K derived: sum of 3 quarters · filed 2026-02-26 | $78.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $28.00K 10-Q · filed 2024-05-09 | $51.00K derived: sum of 2 quarters · filed 2026-02-26 | $52.00K derived: sum of 3 quarters · filed 2026-02-26 | $97.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $24.00K derived: sum of 2 quarters · filed 2026-02-26 | $69.00K derived: sum of 3 quarters · filed 2026-02-26 | $91.00K 10-K · filed 2026-02-26 | |
| 2023-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $46.00K derived: sum of 2 quarters · filed 2024-11-12 | $68.00K 10-Q · filed 2024-11-12 | $101.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $67.00K 10-Q · filed 2024-08-08 | $100.00K derived: sum of 3 quarters · filed 2025-02-27 | $116.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $22.00K 10-Q · filed 2024-05-09 | $55.00K derived: sum of 2 quarters · filed 2025-02-27 | $71.00K derived: sum of 3 quarters · filed 2025-02-27 | $84.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $49.00K derived: sum of 2 quarters · filed 2025-02-27 | $62.00K derived: sum of 3 quarters · filed 2025-02-27 | $72.00K 10-K · filed 2025-02-27 | |
| 2022-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $29.00K derived: sum of 2 quarters · filed 2023-11-09 | $39.00K 10-Q · filed 2023-11-09 | -$3.10M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $23.00K 10-Q · filed 2023-08-09 | -$3.12M derived: sum of 3 quarters · filed 2024-02-29 | -$5.70M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $10.00K 10-Q · filed 2023-05-10 | -$3.13M derived: sum of 2 quarters · filed 2024-02-29 | -$5.71M derived: sum of 3 quarters · filed 2024-02-29 | -$5.89M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$5.72M derived: sum of 2 quarters · filed 2024-02-29 | -$5.90M derived: sum of 3 quarters · filed 2024-02-29 | -$6.07M 10-K · filed 2024-02-29 | |
| 2021-09-30 | -$2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$2.76M derived: sum of 2 quarters · filed 2022-11-09 | -$2.92M 10-Q · filed 2022-11-09 | -$4.28M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | -$176.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$340.00K 10-Q · filed 2022-08-09 | -$1.69M derived: sum of 3 quarters · filed 2023-03-01 | -$1.68M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | -$164.00K 10-Q · filed 2022-05-10 | -$1.52M derived: sum of 2 quarters · filed 2023-03-01 | -$1.50M derived: sum of 3 quarters · filed 2023-03-01 | -$487.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | -$1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$1.34M derived: sum of 2 quarters · filed 2023-03-01 | -$323.00K derived: sum of 3 quarters · filed 2023-03-01 | -$476.00K 10-K · filed 2023-03-01 | |
| 2020-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.03M derived: sum of 2 quarters · filed 2021-11-09 | $878.00K 10-Q · filed 2021-11-09 | $663.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $864.00K 10-Q · filed 2021-08-09 | $649.00K derived: sum of 3 quarters · filed 2022-03-01 | $383.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | -$153.00K 10-Q · filed 2021-05-11 | -$368.00K derived: sum of 2 quarters · filed 2022-03-01 | -$634.00K derived: sum of 3 quarters · filed 2022-03-01 | -$831.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | -$215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$481.00K derived: sum of 2 quarters · filed 2022-03-01 | -$678.00K derived: sum of 3 quarters · filed 2022-03-01 | -$930.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$266.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$463.00K derived: sum of 2 quarters · filed 2020-11-09 | -$715.00K 10-Q · filed 2020-11-09 | -$977.00K derived: sum of 4 quarters · filed 2021-03-16 | |
| 2019-06-30 | -$197.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$449.00K 10-Q · filed 2020-08-10 | -$711.00K derived: sum of 3 quarters · filed 2021-03-16 | -$547.00K derived: sum of 4 quarters · filed 2021-03-16 | |
| 2019-03-31 | -$252.00K 10-Q · filed 2020-05-11 | -$514.00K derived: sum of 2 quarters · filed 2021-03-16 | -$350.00K derived: sum of 3 quarters · filed 2021-03-16 | -$65.00K derived: sum of 4 quarters · filed 2021-03-16 | |
| 2018-12-31 | -$262.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$98.00K derived: sum of 2 quarters · filed 2021-03-16 | $187.00K derived: sum of 3 quarters · filed 2021-03-16 | $316.00K 10-K · filed 2021-03-16 | $56.00K 10-K · filed 2019-03-18 |
| 2018-09-30 | $164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $449.00K derived: sum of 2 quarters · filed 2019-11-12 | $578.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $285.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $414.00K 10-Q · filed 2019-08-09 | |||
| 2018-03-31 | $129.00K 10-Q · filed 2019-05-10 | ||||
| 2017-12-31 | $159.00K 10-K · filed 2020-03-09 | $100.00K 10-K · filed 2019-03-18 | |||
| 2016-12-31 | $35.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |